Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2003-07-22

Original market date: See footnote 1

1994-12-31

Product name:

NOVAHISTEX DH EXPECTORANT

DIN:

02049457 Electronic product monograph is not available

Company:

AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Syrup

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

48:08.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS

Active ingredient group (AIG) number:See footnote5

0300726001

List of active ingredient(s)
Active ingredient(s) Strength
GUAIFENESIN 200 MG / 5 ML
HYDROCODONE BITARTRATE 5 MG / 5 ML
PHENYLEPHRINE HYDROCHLORIDE 20 MG / 5 ML
Version 4.0.2
Date modified: